Ignite Creation Date:
2025-12-24 @ 9:37 PM
Ignite Modification Date:
2025-12-30 @ 9:03 PM
Study NCT ID:
NCT05369832
Status:
TERMINATED
Last Update Posted:
2025-05-20
First Post:
2022-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-11
Completion Date Type:
ACTUAL
First Submit Date:
2022-05-06
First Submit QC Date:
None
Study First Post Date:
2022-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-15
Last Update Post Date:
2025-05-20
Last Update Post Date Type:
ACTUAL